Prelude Capital Management’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,490	Closed	-$43K	–	1944
2020 Q1	$43K	Sell	1,490 -2,332	-61%	-$94.3K	0.01%	790
2019 Q4	$198K	Buy	+3,822	New	+$222K	0.03%	859
2019 Q1	–	Sell	-4,865	Closed	-$164K	–	1747
2018 Q4	$164K	Buy	+4,865	New	+$176K	0.02%	791
2018 Q3	–	Sell	-3,207	Closed	-$103K	–	1716
2018 Q2	$103K	Buy	+3,207	New	+$132K	0.01%	906
2017 Q4	–	Hold	0	–	–	–	1348
2017 Q3	–	Hold	0	–	–	–	1607
2017 Q2	–	Hold	0	–	–	–	1587
2017 Q1	–	Hold	0	–	–	–	1485
2016 Q4	–	Sell	-1,067	Closed	-$51K	–	1528
2016 Q3	$51K	Buy	+1,067	New	+$52.7K	0.01%	1031
2015 Q2	–	Sell	-4,600	Closed	-$189K	–	1675
2015 Q1	$189K	Buy	+4,600	New	+$186K	0.03%	676
2014 Q3	–	Sell	-2,769	Closed	-$128K	–	1847
2014 Q2	$128K	Buy	2,769 +800	+41%	+$35.6K	0.02%	990
2014 Q1	$81K	Buy	+1,969	New	+$73.2K	0.01%	1107